
Switching to a different second-generation antipsychotic zzso with a lower risk of weight gain is recommended for overweight or obese psychiatric patients undergoing zzso zzso However, there have been no complete reports regarding the long-term zzso effects of switching to zzso In this zzso zzso study, we investigated the effects on body weight and other zzso profiles when psychiatric patients treated with another zzso were switched to zzso zzso zzso schizophrenia or zzso zzso with a body mass index greater than 27 zzso were enrolled in the switch zzso These patients were zzso to zzso treatment and followed up for 1 year zzso Another 46 zzso matched with the baseline body mass index of those in the switch group were enrolled as the control group zzso The results showed that the switch group had greater weight loss than the control group zzso zzso zzso vs zzso zzso zzso zzso zzso zzso analysis of zzso P zzso During the treatment course, the zzso patients showed significantly decreased zzso zzso total cholesterol, zzso and insulin resistance zzso decreased zzso blood pressure and pulse zzso and a significant increase in zzso zzso cholesterol levels after switching to zzso (all with a P zzso The prevalence of zzso syndrome in zzso patients also decreased significantly from zzso to zzso zzso test, P zzso These findings suggest that switching to zzso could be an effective treatment of overweight or obese psychiatric patients treated previously with other zzso 

